K. Packer

Associations of Sputum Biomarkers with Clinical Outcomes in People with Cystic Fibrosis

R. Szczesniak, J. Clancy, A. Quittner, 2022, medRxiv.

Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosis

R. Keogh, J. Clancy, A. Quittner, 2019, BMC Medical Research Methodology.

SARS‐CoV‐2 innate effector associations and viral load in early nasopharyngeal infection

K. Tardif, T. Liou, C. Kartsonaki, 2021, Physiological reports.

SARS-CoV-2 Innate Effector Associations and Viral Load in Early Nasopharyngeal Infection

K. Tardif, T. Liou, C. Kartsonaki, 2020, medRxiv.

Sputum Biomarkers and the Prediction of Clinical Outcomes in Patients with Cystic Fibrosis

R. Keogh, R. Paine, T. Liou, 2012, PloS one.

Sleep Phase Delay in Cystic Fibrosis: A Potential New Manifestation of Cystic Fibrosis Transmembrane Regulator Dysfunction

Christopher R. Jones, T. Liou, C. Kartsonaki, 2017, Chest.

Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis

R. Szczesniak, A. Quittner, R. Paine, 2024, iScience.